A monoclonal antibody against the oncogenic mucin 1 cytoplasmic domain

Hybridoma

Volumn 30, Issue 6, 2011, Pages 531-535

  Panchamoorthy, Govind ^a   Rehan, Hala ^a   Kharbanda, Akriti ^a   Ahmad, Rehan ^a   Kufe, Donald ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FORMALDEHYDE; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; MUCIN 1; PARAFFIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; SOLID TUMOR;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGEN-ANTIBODY REACTIONS; CELL LINE, TUMOR; EPITOPE MAPPING; EPITOPES; ESCHERICHIA COLI; HUMANS; HYBRIDOMAS; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; ISOPROPYL THIOGALACTOSIDE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUCIN-1; PROTEIN STRUCTURE, TERTIARY; STOMACH; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL;

EID: 83455238243     PISSN: 15540014     EISSN: 15578348     Source Type: Journal    
DOI: 10.1089/hyb.2011.0070     Document Type: Article

References (19)

1. Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, and Schlom J: Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 1984;3:223-232 (Pubitemid 15184701)
2. Kufe D: Targeting the MUC1 oncoprotein: a tale of two proteins. Cancer Biol Ther 2008;7:81-84 (Pubitemid 351590457)
3. Kufe D: Mucins in cancer: function, prognosis and therapy. Nature Reviews Cancer 2009;9:874-885
4. Kufe D: Functional targeting of the MUC1 oncogene in human cancers. Cancer Biol Ther 2009;8:1201-1207
5. Perey L, Hayes DF, Maimonis P, Abe M, O'Hara C, and Kufe DW: Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res 1992;52:2563-2568
6. Schroeder J, Thompson M, Gardner M, and Gendler S: Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J Biol Chem 2001;276:13057-13064
7. Li Y, Liu D, Chen D, Kharbanda S, and Kufe D: Human DF3/MUC1 carcinoma-associated protein functions as an oncogene. Oncogene 2003;22:6107-6110 (Pubitemid 37175889)
8. Huang L, Chen D, Liu D, Yin L, Kharbanda S, and Kufe D: MUC1 oncoprotein blocks GSK3b-mediated phosphorylation and degradation of b-catenin. Cancer Res 2005;65: 10413-10422 (Pubitemid 41743735)
9. Ramasamy S, Duraisamy S, Barbashov S, Kawano T, Kharbanda S, and Kufe D: The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop. Mol Cell 2007;27:992-1004 (Pubitemid 47488189)
10. Leng Y, Cao C, Ren J, Huang L, Chen D, Ito M, and Kufe D: Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62. J Biol Chem 2007;282:19321-19330 (Pubitemid 47100108)
11. Raina D, Ahmad R, Joshi M, Yin L, Wu Z, Kawano T, Vasir B, Avigan D, Kharbanda S, and Kufe D: Direct targeting of the MUC1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells. Cancer Res 2009;69:5133-5141
12. Zhou J, Rajabi H, and Kufe D: MUC1-C oncoprotein is a target for small molecule inhibitors. Mol Pharm 2011;79: 886-893
13. Ahmad R, Rajabi H, Kosugi M, Joshi M, Alam M, Vasir B, Kawano T, Kharbanda S, and Kufe D: MUC1-C oncoprotein promotes STAT3 activation in an auto-inductive regulatory loop. Sci Signaling 2011;4:ra9
14. Raina D, Kosugi M, Ahmad R, Panchamoorthy G, Rajabi H, Alam M, Shimamura T, Shapiro G, Supko J, Kharbanda S, and Kufe D: Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells. Mol Cancer Ther 2011; 10:806-816
15. Linden SK, Sheng YH, Every AL, Miles KM, Skoog EC, Florin TH, Sutton P, and McGuckin MA: MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS Pathog 2009;5:e1000617
16. Khodarev N, Pitroda S, Beckett M, MacDermed D, Huang L, Kufe D, and Weichselbaum R: MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer. Cancer Res 2009;69: 2833-2837
17. Pitroda S, Khodarev N, Beckett M, Kufe D, and Weichselbaum R: MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment. Proc Natl Acad Sci USA 2009;106:5837-5841
18. MacDermed DM, Khodarev NN, Pitroda SP, Edwards DC, Pelizzari CA, Huang L, Kufe DW, and Weichselbaum R: MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients. BMC Med Genom 2010;3:16
19. Lo AS, Zhu Q, and Marasco WA: Intracellular antibodies (intrabodies) and their therapeutic potential. Handb Exp Pharmacol 2008;343-373.